Literature DB >> 12728467

Colonic transit time in diabetic patients--comparison with healthy subjects and the effect of autonomic neuropathy.

Hye-Kyung Jung1, Doe-Young Kim, Il-Hwan Moon, Young-Sun Hong.   

Abstract

Constipation and the use of laxatives are relatively common in patients with diabetes mellitus. However, the mechanisms responsible for the constipation are unclear. Even though autonomic neuropathy is regarded as one of the important mechanisms of constipation, it requires further clarification. In addition, the colonic function in diabetic patients requires further investigation. The aim of this study was to compare the colonic transit time between patients with diabetes mellitus and healthy subjects, and correlate it to the presence of cardiovascular autonomic neuropathy. The colonic transit time was measured by a noninvasive, radio-opaque marker method, and the presence of cardiovascular autonomic neuropathy was evaluated by the beat-to-beat variation and the orthostatic hypotension. Constipation was defined by the Rome II criteria. The mean total colonic transit time of the 28 diabetic patients (34.9 +/- 29.6 h, mean +/- S.D.) was significantly longer than that of the 28 healthy subjects (20.4 +/- 15.6 h, p < 0.05). Among the diabetic patients, 9/28 (32%) had constipation and 14/28 (50%) had cardiovascular autonomic neuropathy. The diabetic patients with constipation showed longer total, left and recto-sigmoid colonic transit times than those without constipation. However, the mean colonic transit time of diabetic patients with and those without cardiovascular autonomic neuropathy was similar. In conclusion, other mechanisms than the mere presence of cardiovascular autonomic neuropathy might be more relevant to the development of constipation in patients with diabetes mellitus.

Entities:  

Mesh:

Year:  2003        PMID: 12728467     DOI: 10.3349/ymj.2003.44.2.265

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  22 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

2.  Prediction of drug disposition in diabetic patients by means of a physiologically based pharmacokinetic model.

Authors:  Jia Li; Hai-Fang Guo; Can Liu; Zeyu Zhong; Li Liu; Xiao-Dong Liu
Journal:  Clin Pharmacokinet       Date:  2015-02       Impact factor: 6.447

3.  Morphofunctional changes underlying intestinal dysmotility in diabetic RIP-I/hIFNβ transgenic mice.

Authors:  Anna Domènech; Gianandrea Pasquinelli; Roberto De Giorgio; Alessandra Gori; Fàtima Bosch; Martí Pumarola; Marcel Jiménez
Journal:  Int J Exp Pathol       Date:  2011-11-03       Impact factor: 1.925

Review 4.  Diabetes-related dysfunction of the small intestine and the colon: focus on motility.

Authors:  Viktor József Horváth; Zsuzsanna Putz; Ferenc Izbéki; Anna Erzsébet Körei; László Gerő; Csaba Lengyel; Péter Kempler; Tamás Várkonyi
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

5.  Influence of gestational diabetes on the stereoselective pharmacokinetics and placental distribution of metoprolol and its metabolites in parturients.

Authors:  Natalícia de Jesus Antunes; Ricardo Carvalho Cavalli; Maria Paula Marques; Elaine Christine Dantas Moisés; Vera Lucia Lanchote
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

6.  Aerobic exercise improves gastrointestinal motility in psychiatric inpatients.

Authors:  Yeon Soo Kim; Bong Kil Song; Ji Sun Oh; Seung Seok Woo
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

7.  A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation.

Authors:  Adil E Bharucha; Phillip Low; Michael Camilleri; Erica Veil; Duane Burton; Yogish Kudva; Pankaj Shah; Tonette Gehrking; Alan R Zinsmeister
Journal:  Gut       Date:  2012-06-07       Impact factor: 23.059

8.  Ghrelin improves delayed gastrointestinal transit in alloxan-induced diabetic mice.

Authors:  Wen-Cai Qiu; Zhi-Gang Wang; Ran Lv; Wei-Gang Wang; Xiao-Dong Han; Jun Yan; Yu Wang; Qi Zheng; Kai-Xing Ai
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

9.  Prokinetic effects of a ghrelin receptor agonist GHRP-6 in diabetic mice.

Authors:  Qi Zheng; Wen-Cai Qiu; Jun Yan; Wei-Gang Wang; Song Yu; Zhi-Gang Wang; Kai-Xing Ai
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

10.  Colon transit time according to physical activity level in adults.

Authors:  Bong Kil Song; Kang Ok Cho; Yunju Jo; Jung Woo Oh; Yeon Soo Kim
Journal:  J Neurogastroenterol Motil       Date:  2012-01-16       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.